EP MU Readiness and Attestation: What are the Key Ingredients for Success? 02.23, 9:45-10:45am

TriMed Staff | | Health Exec | EMR/EHR
Learn how UMass Memorial developed a comprehensive MU EP strategy and attestation project plan for a physician-centric community and transitioned practices to workflows focused on data entry and collection.

Time:
Thursday, Feb. 23, 9:45am-10:45am

Speaker Information:
Patricia A. Newcomb, BSN, RN, Meaningful Use Project Manager - UMMHC, Encore Health Resources
Karen M. Marhefka, MHA,  Associate Chief Information Officer, UMass Memorial Health Care

Objectives:
  • State what challenges are faced when rolling out MU attestation strategy in the eligible professional (EP) or practice setting
  • Describe how to use a scorecard to promote physician EHR use
  • Explain what changes need to occur at the user level to capture data for reporting
  • Share what roles/positions are critical for the Ambulatory Governance Committee and explain why each one is important
  • Describe effective training strategies for EPs

TriMed Staff

Related Content

Academic health system working on AI dictation feature for Epic
Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions
PHOTO GALLERY: The Epic intergalactic headquarters art collection
AI brings cardiology, neurology teams together to boost care for stroke patients
Best in KLAS: End-users review top health IT systems in the US
More than words: AI takes NLP to the next level to identify signs of heart failure

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.